Joshua L. Walker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joshua L. Walker has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Christian Jacobsen
Department of Cardiothoracic Surgery, UT Health, San Antonio, USA
1 shared publication Edward Darling
State University of New York Upstate Medical University, Department of Cardiovascular Perfusion, Department of Surgery, Syracuse, New York
1 shared publication- Edward Y. Sako
Univ Texas Hlth Sci Ctr San Antonio, Dept Cardiothorac Surg, Mail Code 7841,7703 Floyd Curl Dr, San Antonio, TX 78229 USA
1 shared publication - John Calhoon
Department of Cardiothoracic Surgery, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA
1 shared publication Jonathan Gelfond
†University of Texas Health Science Center at San Antonio, Department of Epidemiology and Biostatistics, San Antonio, Texas
1 shared publicationLee Ann Zarzabal
†University of Texas Health Science Center at San Antonio, Department of Epidemiology and Biostatistics, San Antonio, Texas
1 shared publication
Latest Publications
- 10 June 2022
- Published by Springer Nature in Health Services and Outcomes Research Methodology
- Vol. 23 (2) , 166-184
Dealing with endogeneity in non-randomized medical studies: a study of acute kidney injury following cardiopulmonary bypass surgery
- 10 June 2022
- Published by Springer Nature in Health Services and Outcomes Research Methodology
- Vol. 23 (2) , 166-184
Dealing with endogeneity in non-randomized medical studies: a study of acute kidney injury following cardiopulmonary bypass surgery
- 1 September 2009
- Published by SAGE Publications in Perfusion
- Vol. 24 (5) , 333-339
Calculating mixed venous saturation during veno-venous extracorporeal membrane oxygenation
Introduction: Recirculation (R), the shunting of arterial blood back into to the venous lumen, commonly occurs during veno-venous extracorporeal membrane oxygenation (VV-ECMO) and renders the monitoring of the venous line oxygen saturation no longer reflective of patient mixed venous oxygen saturation (SVO2). Previously, we failed to prove the hypothesis that, once R is known, it is possible to calculate the SVO2 of a patient on VV-ECMO. We hypothesize that we can calculate SVO2 during VV-ECMO if we account for and add an additional correction factor to our model for dissolved oxygen content. Therefore, the purpose of this study is to derive a more accurate model that will allow clinicians to determine SVO2 during VV-ECMO when ultrasound dilution is being used to quantify R. Methods : Using an extracorporeal circuit primed with fresh porcine blood, two stocks of blood were produced; (1) arterial blood (AB), and (2) venous blood (VB). To mimic recirculation, the AB and VB were mixed together in precise ratios using syringes and a stopcock manifold. Six paired stock AB/VB sets were prepared. Two sets were mixed at 20% R increments and 4 sets were mixed at 10% R increments. The partial pressure of oxygen (pO2 ) and oxygen (O2) saturation of the stock blood and resultant mixed blood was determined. The original model was modified by modeling the residual errors with linear regression. Results: When using the original model, as the partial pressure of arterial oxygen (PaO 2) of the stock AB increased, the calculated SVO2 was higher than actual, especially at higher R levels. An iteration of the original model incorporating the PaO2 level (low, medium, high) and R was derived to fit the data. Conclusions : The original model using R and circuit saturations for the calculation of SVO 2 in VV-ECMO patients is an oversimplification that fails to consider the influence of the high pO2 of arterial blood during therapy. In the future, further improvements in this model will allow clinicians accurately to calculate SVO2 in conjunction with recirculation measurements.
- 1 September 2009
- Published by SAGE Publications in Perfusion
- Vol. 24 (5) , 333-339
Calculating mixed venous saturation during veno-venous extracorporeal membrane oxygenation
Introduction: Recirculation (R), the shunting of arterial blood back into to the venous lumen, commonly occurs during veno-venous extracorporeal membrane oxygenation (VV-ECMO) and renders the monitoring of the venous line oxygen saturation no longer reflective of patient mixed venous oxygen saturation (SVO2). Previously, we failed to prove the hypothesis that, once R is known, it is possible to calculate the SVO2 of a patient on VV-ECMO. We hypothesize that we can calculate SVO2 during VV-ECMO if we account for and add an additional correction factor to our model for dissolved oxygen content. Therefore, the purpose of this study is to derive a more accurate model that will allow clinicians to determine SVO2 during VV-ECMO when ultrasound dilution is being used to quantify R. Methods : Using an extracorporeal circuit primed with fresh porcine blood, two stocks of blood were produced; (1) arterial blood (AB), and (2) venous blood (VB). To mimic recirculation, the AB and VB were mixed together in precise ratios using syringes and a stopcock manifold. Six paired stock AB/VB sets were prepared. Two sets were mixed at 20% R increments and 4 sets were mixed at 10% R increments. The partial pressure of oxygen (pO2 ) and oxygen (O2) saturation of the stock blood and resultant mixed blood was determined. The original model was modified by modeling the residual errors with linear regression. Results: When using the original model, as the partial pressure of arterial oxygen (PaO 2) of the stock AB increased, the calculated SVO2 was higher than actual, especially at higher R levels. An iteration of the original model incorporating the PaO2 level (low, medium, high) and R was derived to fit the data. Conclusions : The original model using R and circuit saturations for the calculation of SVO 2 in VV-ECMO patients is an oversimplification that fails to consider the influence of the high pO2 of arterial blood during therapy. In the future, further improvements in this model will allow clinicians accurately to calculate SVO2 in conjunction with recirculation measurements.